Diaceutics PLC
DIUXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 35.7% | 21.5% | 39.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 87.9% | 83.2% | 72% | 75.8% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 8.6% | 10.1% | 18.5% | 15.1% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -5.3% | -7.4% | 3.7% | 4% |
| EPS Diluted | -0.02 | -0.021 | 0.008 | 0.007 |
| % Growth | 2.4% | -346.4% | 27.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |